If your Cartiva synthetic cartilage implant failed and you required revision fusion surgery, you may be entitled to significant financial compensation. With MDL 3172 consolidated in February 2026 and litigation now actively organizing before a federal judge, now is the critical window to benchmark your potential damages before trial outcomes reshape settlement values across the litigation. This Cartiva implant failure damages calculator guide breaks down exactly how attorneys and courts value these claims — covering revision surgery costs, lost wages, pain and suffering tiers, and how MDL consolidation affects your negotiating position.
What Is the Cartiva MDL and Why Does It Matter for Your Damages?
Cartiva SCI (Synthetic Cartilage Implant) devices — small plugs of polyvinyl alcohol hydrogel inserted into the big toe joint — were marketed as a motion-preserving alternative to fusion surgery for hallux rigidus (big toe arthritis). For thousands of patients, the promise turned into a painful failure. Justia’s products liability framework for defective medical devices applies directly to these claims: when a device causes foreseeable harm due to design or manufacturing defects, manufacturers bear strict liability.
Cartiva cases were consolidated into MDL 3172 in February 2026, placing all federal claims before one judge for coordinated pretrial proceedings. As of July 1, 2026, 21 lawsuits are pending in the MDL, with a federal judge having scheduled the first status conference for August 19, 2026, bringing together attorneys representing both plaintiffs and defendants to begin formally organizing the litigation. While no confirmed bellwether trial date yet exists on the court’s own docket, this organizational phase matters enormously for your individual claim: bellwether trials serve as financial weather vanes — the jury verdict in the first trial will anchor settlement negotiations for every subsequent plaintiff.
Stryker’s October 2024 recall of Cartiva devices, citing failure rates that exceeded FDA approval assumptions, significantly strengthened plaintiffs’ positions by establishing that even the manufacturer acknowledged the device was defective. Independent studies have since reinforced that point dramatically, finding that Cartiva implants failed at rates up to 79% within two years — compared to the 13% failure rate Stryker used to gain FDA approval in the first place. The MDL’s coordination means your attorney can leverage shared discovery, pooled expert witnesses, and collective bargaining power that individual lawsuits simply cannot match.
How the Cartiva Implant Failure Damages Calculator Works
Our Cartiva implant failure damages calculator is built around the three core categories that courts and defense attorneys use to value these specific claims. Unlike general personal injury valuations, Cartiva claims carry distinctive damage profiles because the failure mechanism — a shrinking hydrogel plug that destabilizes the entire metatarsophalangeal joint — creates a highly predictable cascade of medical, economic, and quality-of-life harms. Understanding each category is essential before you can accurately estimate your settlement range.
Category 1: Medical Costs and Revision Surgery Expenses
James Mitchell is a personal injury legal researcher with over a decade of experience analyzing settlement data and compensation trends across the United States. He has studied thousands of personal injury cases to help injury victims understand their legal rights and the potential value of their claims. James is not an attorney and the information he provides is for
educational purposes only.